- Merck & Co. (Boston, MA)
- …and accountable for the end-to-end lifecycle management for our company's late - stage multi-tumor assets. This includes the breadth/depth of development ... launches. The Vice President (VP) will work collaboratively with Oncology VP TA heads directly as well as through...of Asset Team Leads who will develop individual molecule late - stage development plans; will work across TA… more
- Pfizer (Cambridge, MA)
- …development strategy for programs within the Late - Stage Oncology portfolio. **Key Responsibilities** + Clinical development professional maintaining ... RAVE, SpotFire, SOCs-PRO or other similar platform **Preferred Qualifications** + Industry/CRO Clinical Research experience in Oncology + Oncology Fellowship… more
- Sumitomo Pharma (Boston, MA)
- … operations. + Provide day-to-day practical and overarching strategic guidance for Oncology clinical programs, ensuring that the design, implementation, and ... and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery,...analysts. + Oversee, plan, and manage the budget for Oncology clinical development activities. + Partner with… more
- Sumitomo Pharma (Boston, MA)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... + Represent the Company at national, regional, and local oncology meetings and conferences. + Maintain clinical ...Canada, and Europe, a diverse pipeline of early- to late - stage assets, and in-house advanced technology capabilities,… more
- Merck (Boston, MA)
- …and accountable for the end-to-end lifecycle management for our company's late - stage multi-tumor assets. This includes the breadth/depth of development ... launches. The Vice President (VP) will work collaboratively with Oncology VP TA heads directly as well as through...of Asset Team Leads who will develop individual molecule late - stage development plans; will work across TA… more
- Merck (Boston, MA)
- …mechanistic PK-PD models and QSP models for decision making in early and/or late - stage clinical development + Experience with mechanistic modeling for ... to clinical pharmacology, mechanistic PK-PD modeling and pharmacometrics of oncology drugs from post-PCC to registration. Directors are leaders in the field… more
- Sumitomo Pharma (Boston, MA)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... packaging and labeling, distribution, returns and destruction) for assigned clinical programs in early and late phases....Canada, and Europe, a diverse pipeline of early- to late - stage assets, and in-house advanced technology capabilities,… more
- Sumitomo Pharma (Boston, MA)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... products in the US, Canada, and Europe, a diverse pipeline of early- to late - stage assets, and in-house advanced technology capabilities, we aim to accelerate… more
- Astellas Pharma (Boston, MA)
- …for assigned sites for specific trials. Trials may include both early and late phase clinical trials. + Develops meaningful site relationships through consistent ... our website at www.astellas.com . **Purpose and Scope:** A Clinical Site Monitor serves as the primary contact point...Reports to the regional Site Management Lead Early or Late - Stage Site Monitoring & Management Organization. This… more
- Takeda Pharmaceuticals (Boston, MA)
- …review and approve operational due diligence for new compounds/alliances (both early and late stage ); partner with TAU/BU representatives and the Centralized Due ... at Takeda. Join us as the Executive Director of Clinical Operations reporting to the Head of Global ...a role model for Takeda's values. Competencies: + Deep oncology experience through Phases I-IV. + Managing large complex… more
- Bristol Myers Squibb (Cambridge, MA)
- …Development is part of the Global Research organization in BMS and leads late stage clinical , pharmacological and translational research and development ... activities for the pipeline and supports late stage portfolio for regulatory, translational development and life cycle management. Translational Development… more
- Bristol Myers Squibb (Cambridge, MA)
- …Development is part of the Global Research organization in BMS and leads late stage clinical , pharmacological and translational research and development ... activities for the pipeline and supports late stage portfolio for regulatory, translational development and life cycle management. Translational Development… more
- Bristol Myers Squibb (Cambridge, MA)
- …health authorities. Includes understanding of impact for each of these on early and late - stage development. + Proven track record of development of immune ... at work and in their personal lives. Read more: careers.bms.com/working-with-us . The Oncology Thematic Research Center at BMS is a key research and early… more
- Sumitomo Pharma (Boston, MA)
- …HCP behavior, engagement trends, and promotional best practices. + Strong understanding of oncology clinical data, with the ability to translate science into ... and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery,...lead the HCP strategy and execution for a key oncology brand with a strong clinical profile… more
- Bayer (Cambridge, MA)
- …indications, representing the full value chain from pre-D1 up to hand-over to late - stage drug development (following Proof-of-Concept and the decision to enter ... for the successful execution of development programs on behalf of Early Clinical Development Oncology , providing clinical -scientific leadership for one… more
- Sumitomo Pharma (Boston, MA)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... products in the US, Canada, and Europe, a diverse pipeline of early- to late - stage assets, and in-house advanced technology capabilities, we aim to accelerate… more
- Bristol Myers Squibb (Cambridge, MA)
- …Research organization that facilitates the transition of drug candidates from early to late - stage clinical development, their approval and life cycle ... on deep understanding of drug mechanism of action and disease segments. Late - stage translational development activities build upon the early work, additionally… more
- Sumitomo Pharma (Boston, MA)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... products in the US, Canada, and Europe, a diverse pipeline of early- to late - stage assets, and in-house advanced technology capabilities, we aim to accelerate… more
- Bristol Myers Squibb (Cambridge, MA)
- …skill sets in academia + Experience with translational/biomarker strategies for early or late stage clinical trials or investigator sponsored trials in ... with proven track record of publications + Understanding of early or late - stage drug and translational development process; including experience with… more
- Sumitomo Pharma (Boston, MA)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... products in the US, Canada, and Europe, a diverse pipeline of early- to late - stage assets, and in-house advanced technology capabilities, we aim to accelerate… more